-
Product Insights
NewPrecision Biologics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Precision Biologics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. It provides services such as development of pharmaceutical and diagnostic products for the early detection and treatment of cancer...
-
Product Insights
NewTelo Genomics Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Telo Genomics Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Telo Genomics Corp (Telo Genomics) is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company's pipeline products include 3D Telo-PC a tool that is used to treat prostate cancer. It also provides 3D Telo-RS a diagnostic and prognostic tool used for the treatment of Hodgkin's Lymphoma. Telo Genomics develops diagnostic and prognostic products that...
-
Product Insights
NewColonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Colonoscopes Pipeline Market Report Overview A Colonoscope is a forward-viewing endoscope designed for examination of the entire colon and terminal ileum. A Colonoscope consists of a long and thin flexible tube having a miniature camera and light source at its distal end. The device consists of a tip housing, a flexible insertion tube, and a cord that connects the light source and the tip housing. The distal part of the insertion tube is flexible enough to allow the device to...
-
Product Insights
NewAllarity Therapeutics A/S Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Allarity Therapeutics A/S Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Allarity Therapeutics A/S (Allarity) is formerly Oncology Venture A/S, is a late clinical-stage, precision medicine company. Its pipeline products include dovitinib, to treat second line ovarian cancer; stenoparib, to treat third line ovarian cancer; ixempra, to treat second line metastatic breast cancer; 2X-111, to treat primary brain cancer. The company's drug response predictor (DRP) platform is used to create...
-
Product Insights
NewGenetic Technologies Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Genetic Technologies Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman’s clinical risk factors with scientifically validated genetic biomarkers,...
-
Product Insights
NewTheralink Technologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Theralink Technologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Theralink Technologies Inc (Theralink Technologies) is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as gynecologic cancer, pancreatic cancer, colorectal cancer, breast, prostrate and other cancers. Theralink Technologies intends to help improve cancer outcomes for patients, reveal therapeutic options for oncologists, and support biopharmaceutical drug development....
-
Product Insights
NewOncomark Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Oncomark Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Oncomark Ltd (Oncomark) is a diagnostics company. It develops prognostic and predictive assays for the treatment of cancer. The company’s product portfolio include OncoMasTR, is a novel prognostic assay used to identify the early stage breast cancer. It uses OncoMasTR technology to develop its products. Oncomark‘s research projects are primarily taken for breast cancer, prostate cancer, colorectal cancer and melanoma...
-
Product Insights
NewBurning Rock Biotech Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Burning Rock Biotech Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Burning Rock Biotech Ltd (BRB) is a biotechnology company. It is involved in providing individualized cancer treatment guidance for the patients. The company offers core products such as OncoCompass IO, OncoScreen IO, OncoCompass Target, OncoScreen ParpMatch, Lung Core, Colon Core, Prostate Core, Onco Screen Risk, Lung Core, Colon Core, Prostate Core, Breast Core, Thyro Core, Lymph Plasma and...
-
Product Insights
NewVolitionRX Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our VolitionRX Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. It develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. The company develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and...
-
Product Insights
NewOncoCyte Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our OncoCyte Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. OncoCyte Corp (OncoCyte) is a molecular diagnostic company that develops solutions for the detection and treatment of cancer. The company offers DetermaRx, a predictive molecular test to identify patients with early-stage non-squamous non-small cell lung cancer. It also develops DetermaIO, a gene expression test to identify immunotherapy drug responders; and DetermaCNI, a test used to measure and monitor cancer treatment....